High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Article
Sikic, Danijel, Eckstein, Markus, Weyerer, Veronika, Kubon, Jennifer, Breyer, Johannes, Roghmann, Florian, Kunath, Frank, Keck, Bastian, Erben, Philipp, Hartmann, Arndt, Wirtz, Ralph M., Wullich, Bernd, Taubert, Helge and Wach, Sven (2022) High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer. Urologic Oncology: Seminars and Original Investigations 40 (2), 63.e9-63.e18.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Urologic Oncology: Seminars and Original Investigations | ||||
| Publisher | Elsevier | ||||
| Place of Publication | NEW YORK | ||||
| Volume | 40 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | 63.e9-63.e18 | ||||
| Date | 2022 | ||||
| Date of publication | 29 Feb 2024 12:58 | ||||
| Institutions | Medicine > Lehrstuhl für Urologie | ||||
| Identification Number |
| ||||
| Keywords | ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; TRANSITIONAL-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; UROTHELIAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; GENE AMPLIFICATION; MOLECULAR TAXONOMY; URINARY-BLADDER; BREAST-CANCER; Non-muscle-invasive bladder cancer; ERBB2; Estrogen receptor; HER2; Urothelial carcinoma | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57564 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric